TORRENT DO BRASIL LIMITEDA — Bisoprolol Importer Profile
Pharmaceutical Importer · #19 buyer for Bisoprolol · $2.5M import value · 103 shipments · BRAZIL · DGFT Verified
TORRENT DO BRASIL LIMITEDA is the #19 importer of Bisoprolol from India with $2.5M in import value and 103 verified shipments. TORRENT DO BRASIL LIMITEDA holds a 0.7% market share in Bisoprolol imports based in BRAZIL. The company sources from 1 verified supplier across 65 formulations shipped to 1 country. Overall, TORRENT DO BRASIL LIMITEDA imports 2 pharmaceutical products worth $2.2M across 2 therapeutic categories.
TORRENT DO BRASIL LIMITEDA — Bisoprolol Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Bisoprolol to TORRENT DO BRASIL LIMITEDA?
Verified from 103 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| TORRENT PHARMACEUTICALS LIMITED | $2.5M | 103 | 100.0% |
TORRENT DO BRASIL LIMITEDA sources Bisoprolol from 1 verified Indian supplier based on 103 customs records. The primary supplier is TORRENT PHARMACEUTICALS LIMITED accounting for 100.0% of imports.
Where Does TORRENT DO BRASIL LIMITEDA Import Bisoprolol To?
Destination countries from 103 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| BRAZIL | $2.5M | 103 | 100.0% |
TORRENT DO BRASIL LIMITEDA imports Bisoprolol to 1 country. The primary destination is BRAZIL receiving 100.0% of shipments worth $2.5M.
What Bisoprolol Formulations Does TORRENT DO BRASIL LIMITEDA Import?
| Formulation | Value | Shipments |
|---|---|---|
| OTHER-ICCOR 2.5 MG TABLETS ( BISOPROLOLFUMARATE TABLETS USP 2.5 MG ) (52460X3X10TABS=1573800 TABLETS) | $121.7K | 3 |
| OTHER - BISOPROLOL FUMARATE USP 5MG TABLETS (BISOPROLOL FUMARATE TABLETS USP 5 MG) (115854X3X10 TAB = 3475620 TABLETS) | $100.0K | 2 |
| ICCOR 5MG TABLET (BISOPROLOL FUMARATE TA | $99.0K | 2 |
| ICCOR 2.5MG TABLETS (BISOPROLOL FUMARATE | $85.1K | 4 |
| BISOPROLOL FUMARATE USP 5MG TABLETS (BIS | $81.0K | 2 |
| OTHER - BISOPROLOL FUMAR USP 2.5MG TABLE | $69.1K | 4 |
| OTHER - BISOPROLOL FUMAR. USP 1.25MG TAB | $60.5K | 2 |
| OTHER - ICCOR 5MG TABLET BISOPROLOL FU | $59.1K | 2 |
| OTHER-BISOPROLOL FUMARATE USP 2.5MG TABL | $57.1K | 2 |
| OTHER-BISOPROLOL FUMAR USP 2.5 MG TABLET | $51.2K | 2 |
TORRENT DO BRASIL LIMITEDA imports 65 distinct Bisoprolol formulations from India. The top formulation is OTHER-ICCOR 2.5 MG TABLETS ( BISOPROLOLFUMARATE TABLETS USP with 3 shipments worth $121.7K.
Regulatory Requirements: Importing Bisoprolol into Brazil
What TORRENT DO BRASIL LIMITEDA and other importers must comply with to import Bisoprolol from India
Regulatory Authority
Brazilian Health Regulatory Agency (ANVISA)
Approval Process for Generic Bisoprolol
Generic drug registration under RDC 200/2017. Requires pharmaceutical equivalence and bioequivalence studies. ANVISA GMP inspection of overseas facilities mandatory.
Typical timeline: 12–24 months
GMP Requirements
ANVISA GMP certificate (CBPF) for each manufacturing site; on-site inspection by ANVISA
Import Licence & Documentation
Import Authorization (LI) via SISCOMEX; Sanitary Import Permit from ANVISA
Labeling & Packaging
Portuguese language labeling mandatory; ANVISA registration number
Note: ANVISA maintains an active inspection program for Indian pharma facilities. Inspection backlog can extend timelines significantly.
Regulatory information is provided for general reference based on publicly available ANVISA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with ANVISA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Bisoprolol from India and How Much Does TORRENT DO BRASIL LIMITEDA Import?
India exported $23.4M worth of Bisoprolol through 4,276 shipments from 245 suppliers to 121 countries, serving 585 buyers globally. TORRENT DO BRASIL LIMITEDA imports $2.5M of this total, accounting for 0.7% of India's Bisoprolol exports with 103 shipments from BRAZIL. This is verified from 103 customs shipment records covering 65 distinct formulations.
What Is the Average Order Value for TORRENT DO BRASIL LIMITEDA's Bisoprolol Imports?
TORRENT DO BRASIL LIMITEDA's average Bisoprolol order value is $24.6K per consignment, based on 103 shipments totaling $2.5M. TORRENT DO BRASIL LIMITEDA is based in BRAZIL and ranks #19 among all Bisoprolol importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Bisoprolol to TORRENT DO BRASIL LIMITEDA?
TORRENT DO BRASIL LIMITEDA sources Bisoprolol from 1 verified Indian supplier: TORRENT PHARMACEUTICALS LIMITED ($2.5M, 100.0%). This is based on 103 customs records.
How Does TORRENT DO BRASIL LIMITEDA Compare to Other Bisoprolol Importers?
TORRENT DO BRASIL LIMITEDA ranks #19 among 585 Bisoprolol importers from India with a 0.7% market share. The top 3 importers are UNICHEM PHARMACEUTICALS (USA) INC. ($6.0M), IPCA LABORATORIES UK LIMITED ($3.1M), TORRENT DO BRASIL LTDA ($2.5M). TORRENT DO BRASIL LIMITEDA processed 103 shipments from BRAZIL.
About TORRENT DO BRASIL LIMITEDA
TORRENT DO BRASIL LIMITEDA imports 2 products worth $2.2M. Beyond Bisoprolol, top products include Gliclazide. View the complete TORRENT DO BRASIL LIMITEDA profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Bisoprolol — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Bisoprolol shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: TORRENT DO BRASIL LIMITEDA matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as TORRENT DO BRASIL LIMITEDA's capped import value divided by total capped export value for Bisoprolol across all Indian exporters.
- 5.Verified Records: This page is backed by 103 individual customs records matching TORRENT DO BRASIL LIMITEDA importing Bisoprolol, covering 65 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 121+ countries, 585+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Bisoprolol Import Data for TORRENT DO BRASIL LIMITEDA
Access order-level details, pricing data, supplier connections, and competitive analysis for TORRENT DO BRASIL LIMITEDA's Bisoprolol imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
TORRENT DO BRASIL LIMITEDA
Full Company Profile →
2 products · $2.2M total trade · 2 categories
TORRENT DO BRASIL LIMITEDA × Bisoprolol
Verified from customs records
Company Overview
Top Products by TORRENT DO BRASIL LIMITEDA
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for TORRENT DO BRASIL LIMITEDA.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Bisoprolol. For current order-level data, contact TransData Nexus.